Circulating Tumor DNA After Neoadjuvant Chemotherapy in Breast Cancer Is Associated With Disease Relapse Read More
A phase II study of talazoparib monotherapy in patients with wild-type BRCA1 and BRCA2 with a mutation in other homologous recombination gen Read More
Treatment response monitoring using a tumor-informed circulating tumor DNA test in an advanced triple negative breast cancer patient: A case Read More
Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence risk Magbanua et al. 2021 NPJ Breast Cancer Read More
Circulating tumor DNA in neoadjuvant treated breast cancer reflects response and survival Magbanua et al. 2020 Annals of Oncology Read More
Personalized detection of circulating tumor DNA antedates breast cancer metastatic recurrence Coombes et al. 2019 Clin. Cancer Res. Read More
Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients Wi Christensen et al. 2019 J. Clin. Oncol. Read More
ctDNA guiding adjuvant immunotherapy in urothelial carcinoma Powles T, Assaf ZA, Davarpanah N, et al. Nature. Read More
Final results of neoadjuvant atezolizumab in cisplatin-ineligible patients with muscle-invasive urothelial cancer of the bladder Szabados B, Kockx M, Assaf ZA, et al. European Urology. Read More
Molecular Residual Disease and Efficacy of Adjuvant Chemotherapy in Patients with Colorectal Cancer Read More
Circulating tumor DNA (ctDNA) serial analysis during progression on PD-1 blockade and later CTLA-4 rescue in patients with mismatch repair d Read More
DENEB: Development of new criteria for curability after local excision of pathological T1 colorectal cancer using liquid biopsy Read More
Early detection of circulating tumor DNA post-operatively enables discovery of resectable metastatic disease in a patient with colon cancer Read More
Circulating Tumor DNA in Stage III Colorectal Cancer, beyond Minimal Residual Disease Detection, toward Assessment of Adjuvant Therapy Effic Read More
A multicenter, prospective observational study to evaluate the impact of circulating tumor DNA guided therapy on patients with colorectal ca Read More
Detection of molecular residual disease using personalized circulating tumor DNA assay in colorectal cancer patients undergoing resection of Loupakis et al. 2021 JCO-PO Read More
ctDNA Clearance and Radiographic Resolution of Disease in Response to Dual Checkpoint Inhibition in metastatic microsatellite stable colo... Schneider et al. 2021 Case reports in Onc. Read More